Dr. Gardner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3471 Fifth Avenue
Suite 810 Lkb
Pittsburgh, PA 15213Phone+1 412-692-4920
Education & Training
- University of Utah HealthResidency, Neurology, 1990 - 1993
- University of Utah HealthInternship, Internal Medicine, 1989 - 1990
- University of Utah School of MedicineClass of 1989
Certifications & Licensure
- PA State Medical License 1996 - 2024
- WY State Medical License 1993 - 2024
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Comparison of a Drug and Placebo in the Prevention of Migraine Headaches Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 33 citationsPatient-reported outcomes in neurofibromatosis and schwannomatosis clinical trialsPamela L. Wolters, Staci Martin, Vanessa L. Merker, Kathy Gardner, Cynthia M. Hingtgen
Neurology. 2013-11-19 - 182 citationsGermline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomasArkadiusz Piotrowski, Jing Xie, Ying F Liu, Andrzej Poplawski, Alicia Gomes
Nature Genetics. 2014-02-01 - 175 citationsAutosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1.Kevin M. Flanigan, Kathy Gardner, Alderson K, Galster B, Brith Otterud
American Journal of Human Genetics. 1996-08-01
Press Mentions
- Care Homes and COVID19May 1st, 2022
- Blue Cross Blue Shield of Massachusetts Expands Response to COVID-19 PandemicApril 29th, 2020
- Resources and Tools for Training and HR Professionals to Cope with COVID-19March 23rd, 2020
Grant Support
- Molecular Basis Of Hemiplegic MigraineNational Institute Of Neurological Disorders And Stroke1997–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: